Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,824,233
  • Shares Outstanding, K 516,944
  • Annual Sales, $ 11,501 M
  • Annual Income, $ 16,800 K
  • 60-Month Beta 1.55
  • Price/Sales 0.77
  • Price/Cash Flow 2.05
  • Price/Book 0.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.97
  • Number of Estimates 7
  • High Estimate 1.08
  • Low Estimate 0.75
  • Prior Year 1.03
  • Growth Rate Est. (year over year) -5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.80 +15.38%
on 05/15/20
17.85 -4.37%
on 05/11/20
-0.25 (-1.44%)
since 04/29/20
3-Month
12.75 +33.88%
on 03/16/20
17.85 -4.37%
on 05/11/20
-0.12 (-0.70%)
since 02/28/20
52-Week
12.75 +33.88%
on 03/16/20
23.11 -26.14%
on 02/06/20
-0.93 (-5.17%)
since 05/29/19

Most Recent Stories

More News
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings

and , /PRNewswire/ --  (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged...

MYL : 17.07 (-1.04%)
Mylan Nv (MYL) Breaks Through Resistance at $15.93

Shares of Mylan Nv (NASDAQ:MYL) opened today above their pivot of $15.68 and have already reached the first level of resistance at $15.93. Should the shares continue to rise, the resistance pivots of...

MYL : 17.07 (-1.04%)
Watch for Mylan Nv to Potentially Rebound After Falling 2.56% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $15.56 to a high of $15.97. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $15.84 on...

MYL : 17.07 (-1.04%)
Mylan Nv Set to Possibly Rebound After Yesterday's Selloff of 2.56%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $15.56 to a high of $15.97. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $15.84 on...

MYL : 17.07 (-1.04%)
Top Research Reports for Intel, Adobe & AMD

Top Research Reports for Intel, Adobe & AMD

WYNN : 83.28 (+0.10%)
RE : 198.41 (-2.98%)
MYL : 17.07 (-1.04%)
INTC : 62.93 (+1.99%)
AMD : 53.80 (+3.98%)
ADBE : 386.60 (+1.78%)
% Return Seen to Date on SmarTrend Mylan Nv Call (MYL)

SmarTrend identified a Downtrend for Mylan Nv (NASDAQ:MYL) on March 17th, 2020 at $15.92. In approximately 2 months, Mylan Nv has returned 0.91% as of today's recent price of $16.06.

MYL : 17.07 (-1.04%)
Markets Set Out on Long Journey to Recovery: 4 ROE Picks

ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.

ALL : 97.81 (-0.46%)
MYL : 17.07 (-1.04%)
PGR : 77.68 (+1.42%)
CDNS : 91.29 (+3.67%)
Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference

and , /PRNewswire/ -- Global pharmaceutical company (NASDAQ: MYL) today announced that Executive Chairman and President will present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference...

MYL : 17.07 (-1.04%)
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19

and , /PRNewswire/ --  (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19 pandemic, a global collaboration with Gilead Sciences...

GILD : 77.83 (+3.33%)
MYL : 17.07 (-1.04%)
Is Mylan (MYL) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

MYL : 17.07 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MYL with:

Business Summary

Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as...

See More

Key Turning Points

2nd Resistance Point 17.77
1st Resistance Point 17.42
Last Price 17.07
1st Support Level 16.67
2nd Support Level 16.27

See More

52-Week High 23.11
Fibonacci 61.8% 19.15
Fibonacci 50% 17.93
Last Price 17.07
Fibonacci 38.2% 16.71
52-Week Low 12.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar